Network pharmacology and experimental analysis of Yudantong decoction, a multi-immunomodulator for the treatment of intractable cholestatic liver disease: Identification of active agents, molecular targets, and mechanisms of action
Int. Journal of Clinical Pharmacology and Therapeutics · 2025
DOI: 10.5414/cp204695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Xiaoming Wu und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Network Pharmacology, Drugs, Chinese Herbal, Immunomodulating Agents, Cholestasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Wu, X., Hou, L., Liu, J., Hao, J., Liu, C., Hu, Y., & He, Q. (2025). Network pharmacology and experimental analysis of Yudantong decoction, a multi-immunomodulator for the treatment of intractable cholestatic liver disease: Identification of active agents, molecular targets, and mechanisms of action. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204695
Vancouver
Wu X, Hou L, Liu J, Hao J, Liu C, Hu Y, et al. Network pharmacology and experimental analysis of Yudantong decoction, a multi-immunomodulator for the treatment of intractable cholestatic liver disease: Identification of active agents, molecular targets, and mechanisms of action. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204695
BibTeX
@article{Wu2025,
author = {Wu, Xiaoming and Hou, Linyi and Liu, Jing and Hao, Jing and Liu, Chang and Hu, Yan and He, Qiang},
title = {Network pharmacology and experimental analysis of Yudantong decoction, a multi-immunomodulator for the treatment of intractable cholestatic liver disease: Identification of active agents, molecular targets, and mechanisms of action},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2025},
doi = {10.5414/cp204695}
}
EUVIMED